Real-world efficacy and toxicity of ipilimumab and nivolumab as a first-line treatment for advanced renal cell carcinoma according to IMDC risk criteria-A multi-center retrospective analysis on behalf of the GUARDIANS group
INTERNATIONAL JOURNAL OF CANCER. 2025
Erscheinungsjahr: 2025
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Dinkel, Hendrik (Autor)
Materna, Linus (Autor)
Stelmach, Ramona (Autor)
Zschabitz, Stefanie (Autor)
Neuberger, Stephanie (Autor)
Aydogdu, Can D. (Autor)
Casuscelli, Jozefina (Autor)
Egenolf, Timo (Autor)
Silberg, Matteo (Autor)
Steinestel, Julie (Autor)
Strauss, Arne (Autor)
Kirchhoff, Florian (Autor)
Ahrens, Marit (Autor)
Paffenholz, Pia (Autor)
Cathomas, Richard (Autor)
Ozdemir, Berna C. (Autor)
Gossler, Christopher (Autor)
Ivanyi, Philipp (Autor)
Rehlinghaus, Marc (Autor)
Hilser, Thomas (Autor)
Grunwald, Viktor (Autor)
Schlack, Katrin (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
